IgG4-RD Research

Stay up to date on the latest news and information about IgG4-RD clinical trials and research.

Learn about clinical research studies

Explore ongoing clinical trials

Read the latest IgG4-RD research news

What is a Clinical Trial?

A clinical trial is a research study that tests a new drug or medical device in volunteers to determine the safety and efficacy of the treatment. Information and results from clinical trials are used by regulators, such as the Food and Drug Administration (FDA) in the United States, to determine if a treatment should be approved for use by the general public.

More detailed information about clinical trials can be found at:

Explore IgG4-RD Clinical Trials

There are several IgG4-Related Disease (IgG4-RD) clinical trials currently recruiting volunteer participants in the United States and other countries throughout the world.

Visit ClinicalTrials.gov to explore clinical trials for IgG4-RD or click on the logos included under Featured Trials to view information about studies sponsored by our partners.

Featured Trials

Latest IgG4-RD News & Research Updates

Find all the latest IgG4-RD research news updates here in one place. All the updates we share has been reviewed by our IgG4-RD expert board members, so you can be sure the information is not only relevant, but also derived from a credible source.

A yellow and blue graphic the reads "Question of the Week" "“It’s been more than a year since my last rituximab infusion and my CD20 count is back in the normal range. Why do I not have any signs of an IgG4-RD flare?” At the bottom it reads "IgG4ward!"

Question of the Week: “It’s been more than a year since my last rituximab infusion and my CD20 count is back in the normal range. Why do I not have any signs of an IgG4-RD flare?”

We are pleased to share another edition of the IgG4ward! Question of the Week (QoW) series! This week’s QoW and its answer are below. We…

Blue text reading "AMGEN Rare Disease."

A Letter from Amgen about the top-line results from the MITIGATE trial 

Amgen, a worldwide pioneer in biotechnology and a generous sponsor of the IgG4ward! Foundation, recently announced strongly positive results from its MITIGATE clinical trial. This…

A blue graphic reading "Important Announcement! Amgen announces positive results for Phase 3 Registrational Trial Evaluating Uplizna® (inebilizumab) for treatment of IgG4-Related Disease. IgG4ward!" There are gold megaphones in the bottom left and top right of the graphic.

Long-awaited news from Amgen about the top-line results from the MITIGATE trial! 

Back in 2018 – WAY before the pandemic – I had a conversation with a pharmaceutical company called Viela about doing a clinical trial of…

Thank You to Our Sponsors!

We want to thank all individual contributors who have supported and continue to support IgG4ward!
If your company is interested in supporting IgG4ward!, please contact us using this form.